West Launches New Product Innovations at Pharmapack 2020
In addition, West will share thought leadership insights into biologics and combination products, which are two priority areas in pharmaceutical packaging and delivery innovation today.
"West's priority is to help customers simplify their journey, whether through new products or by helping mitigate risks in the drug development process to accelerate speed to market in today's ever-evolving, complex industry and global regulatory environment," said DeGrazio. "We have deep knowledge of navigating the nuances of biologic drugs and delivery systems even at the earliest stages, including quality systems, design controls and risk management frameworks. By keeping a lens on the unique interface between a drug, its primary package and device, we support our customers with smart, integrated solutions from end to end that help them meet, if not exceed, industry standards."
Company scientific and industry experts will be available at Booth #B58 to discuss West's role in continued innovation in biologics and combination products, to provide insights into the Company's Integrated Solutions offering, and to share additional highlights on the following new product offerings:
- AccelTRA® components program: West launched two line extensions, including its AccelTRA Select EU configurations available in Ready-to-Sterilize (RS) and Ready-to- Use (RU) steam for customers needing a high-performing elastomer and regulatory support in
North America, as well as its AccelTRA ready-to-sterilize (RTS)/ready-to-use (RTU) components product line with the RTS option available now for customers needing a high-performing elastomer and lead-time program support outside North America. Both product lines leverage the next-generation elastomer formula of 4031/45, which features 13mm and 20mm serum and lyo stoppers in eight configurations, offering generics customers optimal quality, speed and simplicity to help get their products to market quickly. In addition to stoppers, the AccelTRA Select components product line also features 1-3mL plungers for generics customers requiring a high-performing solution for their prefilled syringe needs.
- Flip-Off® CCS Seal: The Company launched a Flip-Off CCS Seal to provide customers with a ready-to-use sterile, superior quality capping product for its 5mL Daikyo Crystal Zenith vial. The Flip-Off seal maintains container closure integrity and supports a safe, convenient user experience.
- Ready Pack™ system: As an expansion of West's partnership with
SCHOTT, convenient, ready-to-use combinations of West and SCHOTTproducts will be available on a small quantity basis, including West's Ready Pack system with the SCHOTTadaptiQ® high quality RTU glass vials. The ISO standard vial products are being offered in three sizes: 2R; 6R; and 10R.
- Learning Lab presentation:
Nico Brandes, Director, Market Development, Innovation & Technology at West will host a Learning Labsession entitled, "Design with the End in Mind: Patient-Centric Innovations in Containment and Delivery," on February 6at 11:30 a.m. CEST.
For more information on West products and services, please visit booth #B58 at Pharmapack or visit us online at www.westpharma.com.
West and the diamond logo, AccelTRA®, FLIP-OFF® and Ready Pack™ are trademarks and registered trademarks of
Crystal Zenith® is a registered trademark of Daikyo Seiko, Ltd. Daikyo Crystal Zenith technology is licensed from
Certain forward-looking statements are included in this press release. They use words such as "will," "introduce," "mitigate," "new," "expands," "offer," "accelerate," "future," and other similar terminology. These statements reflect management's current expectations regarding future events and operating performance and speak only as of the date of this release. There is no certainty that actual results will be achieved in-line with current expectations. Specifically, there is no certainty that the AccelTRA® component line extensions or the new FLIP-Off® Seal compatible with the 5mL Crystal Zenith® vial will achieve any particular result. There is also no certainty that our Ready Pack™ system offering in combination with the
West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2018 net sales of $1.7 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world. For more information, visit www.westpharma.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/west-launches-new-product-innovations-at-pharmapack-2020-300998896.html
Emily Denney, Vice President, Global Communications, +1-610-594-3035, Emily.Denney@westpharma.com